LISA DANKO: Open Payments
NPI 1689636193 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,024 in 158 payments from 47 companies in 2025. Trend: 2023 $2,327 · 2024 $4,709 · 2025 $4,024
Food & beverage: $3,825Education: $199
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $421 |
| Novartis Pharmaceuticals Corporation | 16 | $370 |
| Merck Sharp & Dohme LLC | 12 | $283 |
| E.R. Squibb & Sons, L.L.C. | 12 | $256 |
| Janssen Biotech, Inc. | 10 | $223 |
| Ipsen Biopharmaceuticals, Inc | 4 | $194 |
| Exelixis Inc. | 6 | $152 |
| Stemline Therapeutics Inc. | 2 | $145 |
| Lilly USA, LLC | 2 | $122 |
| ABBVIE INC. | 5 | $121 |
Products named: OPDIVO, KEYTRUDA, Onivyde, KISQALI, CABOMETYX, Orserdu, ENHERTU, JAYPIRCA.
Industry payments across IN — which companies pay providers there.
